TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ALVO

Alvotech

Healthcare · Drug Manufacturers - Specialty & Generic

5.90$ -3.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ALVO
Line item 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 0.0% 0.0% 77.2% 175.9% 37.8% 40.2%
100.0% 100.0% 100.0% 22.8% -75.9% 62.2% 59.8%
299.4% 222.3% 519.4% 217.5% 230.6% 35.0% 31.4%
152.2% 88.4% 228.8% 224.9% 79.9% 12.5% 15.5%
292.5% 306.5% 740.3% 440.1% 312.2% 47.9% 46.5%
-192.5% -206.5% -640.3% -417.3% -388.1% 14.2% 13.3%
300.0% 146.3% 307.2% 110.1% 147.5% 32.2% 25.4%
-656.0% -438.0% -405.7% -664.4% -712.0% -44.4% 23.3%
1.5% -182.7% -129.7% -45.8% -108.6% 2.9% 18.5%
-657.5% -255.3% -276.0% -618.6% -603.4% -47.3% 4.8%
-310.2% -267.0% -49.0% -529.7% -539.9% -6.6% 55.2%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?